Filed before 2025Filed 14 February 2012
Phaserx, Inc. raised $3.6M
Phaserx, Inc., a biotech company based in Seattle, WA, raised $3.6M in a new debt round, according to a filing dated 14 February 2012.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 February 2012
- Round
- Debt round
- Amount sold
- $3.6M
- Offering size
- $4.65M
- Investors so far
- 5
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 45% of the 368 tracked raises with an amount filed in 2012, and than 53% of the 32 in biotech.
Phaserx, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Jun 2016 | New filing | None | Another raise |
| 29 Dec 2015 | New filing | $4M | Another raise |
| 14 Feb 2012 | New filing | $3.6M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.